Basics Cardiff Oncology, Inc. IPO Date: August 1, 2004 Sector: Healthcare Industry: Biotech Market Cap: $151.68M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 4.11% Avg Daily Range (30 D): $0.05 | 2.24% Avg Daily Range (90 D): $0.09 | 2.96% Institutional Daily Volume Avg Daily Volume: .9M Avg Daily Volume (30 D): .77M Avg Daily Volume (90 D): 1.46M Trade Size Avg Trade Size (Sh.): 167 Avg Trade Size (Sh.) (30 D): 201 Avg Trade Size (Sh.) (90 D): 199 Institutional Trades Total Inst.Trades: 175 Avg Inst. Trade: $2.02M Avg Inst. Trade (30 D): $1.2M Avg Inst. Trade (90 D): $1.14M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.14M Avg Closing Trade (30 D): $1.63M Avg Closing Trade (90 D): $1.63M Avg Closing Volume: 378.1K     News Mar 8, 2025 @ 12:33 PM Why the Global Cancer Market Could Surpass $900 Bi... Source: Prnewswire Dec 10, 2024 @ 12:20 PM Cardiff Oncology Prices Oversubscribed $40 Million... Source: Globe Newswire Dec 10, 2024 @ 11:00 AM Cardiff Oncology Announces Positive Initial Data f... Source: N/A May 29, 2024 @ 8:05 PM Cardiff Oncology to Present at the Jefferies Healt... Source: Cardiff Oncology, Inc. May 13, 2024 @ 8:05 PM Cardiff Oncology to Present at Upcoming Investor C... Source: Cardiff Oncology, Inc. Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.21 $-.2 $-.25 Diluted EPS $-.21 $-.2 $-.25 Revenue $ .12M $ .11M $ .17M Gross Profit $ $ $ Net Income / Loss $ -13.94M $ -13.43M $ -11.86M Operating Income / Loss $ -14.78M $ -14.38M $ -12.6M Cost of Revenue $ $ $ Net Cash Flow $ -13.31M $ -27.38M $ -12.46M PE Ratio     Splits Feb 20, 2019:   1:6 Jun 04, 2018:   1:12 May 30, 2012:   1:6